Table 3 Frequency of HLA-DRB1 in control and sarcoidosis patients
DR B1* | % patients (n = 86) | % controls (n = 95) | P-value |
|---|---|---|---|
*01 | 6.1% | 10.4% | 0.54 |
*03 | 18.4% | 14.6% | 0.55 |
*04 | 10.2% | 18.4% | 0.18 |
*07 | 4.1% | 17.7% | 0.02 |
*08 | -------- | 5.2% | 0.16 |
*09 | -------- | 1% | 1.0 |
*10 | 12.2% | 5.2% | 0.18 |
*11 | 36.6% | 36.7% | 0.87 |
*12 | 8.2% | 1% | 0.04 |
*13 | 22.4% | 22.9% | 0.95 |
*14 | 20.2% | 12.5% | 0.21 |
*15 | 32.7% | 18.8% | 0.06 |
*16 | 8.2% | 14.6% | 0.27 |